Sen. Hassan Presses the FDA Commissioner to Update Opioid Labeling Policies: 'What People Are Looking for Right Now Is Action'
September 16, 2022
September 16, 2022
WASHINGTON, Sept. 16 -- Sen. Maggie Hassan, D-New Hampshire, issued the following news release on Sept. 15, 2022:
At a U.S. Senate Health, Education, Labor, and Pensions Committee hearing yesterday, U.S. Senator Maggie Hassan pressed Food and Drug Administration (FDA) Commissioner Dr. Robert Califf on the need to update the FDA's harmful labeling policies that continue to play a role in fueling the opioid crisis in New Hampshire. Senator Hassan also asked about taking lessons f . . .
At a U.S. Senate Health, Education, Labor, and Pensions Committee hearing yesterday, U.S. Senator Maggie Hassan pressed Food and Drug Administration (FDA) Commissioner Dr. Robert Califf on the need to update the FDA's harmful labeling policies that continue to play a role in fueling the opioid crisis in New Hampshire. Senator Hassan also asked about taking lessons f . . .